Gut microbiota: a potential new regulator of hypertension
- PMID: 38993521
- PMCID: PMC11236727
- DOI: 10.3389/fcvm.2024.1333005
Gut microbiota: a potential new regulator of hypertension
Abstract
Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and has become a global public health concern. Although hypertension results from a combination of factors, the specific mechanism is still unclear. However, increasing evidence suggests that gut microbiota is closely associated with the development of hypertension. We provide a summary of the composition and physiological role of gut microbiota. We then delve into the mechanism of gut microbiota and its metabolites involved in the occurrence and development of hypertension. Finally, we review various regimens for better-controlling hypertension from the diet, exercise, drugs, antibiotics, probiotics, and fecal transplantation perspectives.
Keywords: blood pressure; gut microbiota; hypertension; lipopolysaccharide; short-chain fatty acids.
© 2024 Ge, Wang, Wu and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Gut microbiota and hypertension: association, mechanisms and treatment.Clin Exp Hypertens. 2023 Dec 31;45(1):2195135. doi: 10.1080/10641963.2023.2195135. Clin Exp Hypertens. 2023. PMID: 36994745 Review.
-
The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.Pharmacol Res. 2019 Mar;141:366-377. doi: 10.1016/j.phrs.2019.01.019. Epub 2019 Jan 10. Pharmacol Res. 2019. PMID: 30639376 Review.
-
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.Pathol Res Pract. 2023 Sep;249:154740. doi: 10.1016/j.prp.2023.154740. Epub 2023 Aug 6. Pathol Res Pract. 2023. PMID: 37567034 Review.
-
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension.Nutrients. 2022 Oct 13;14(20):4278. doi: 10.3390/nu14204278. Nutrients. 2022. PMID: 36296961 Free PMC article. Review.
-
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension.Front Microbiol. 2021 Sep 28;12:730809. doi: 10.3389/fmicb.2021.730809. eCollection 2021. Front Microbiol. 2021. PMID: 34650536 Free PMC article. Review.
Cited by
-
Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patients.J Hypertens. 2025 Sep 1;43(9):1539-1553. doi: 10.1097/HJH.0000000000004086. Epub 2025 Jun 23. J Hypertens. 2025. PMID: 40552387 Free PMC article.
-
Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension.Front Pharmacol. 2024 Dec 9;15:1449972. doi: 10.3389/fphar.2024.1449972. eCollection 2024. Front Pharmacol. 2024. PMID: 39717555 Free PMC article. Review.
-
Takeda G protein-coupled receptor 5 (TGR5): an attractive therapeutic target for aging-related cardiovascular diseases.Front Pharmacol. 2025 Mar 20;16:1493662. doi: 10.3389/fphar.2025.1493662. eCollection 2025. Front Pharmacol. 2025. PMID: 40183075 Free PMC article. Review.
-
Assembled human microbiome and metabolome in chronic kidney disease: Dysbiosis a double-edged sword interlinking Circ-YAP1, Circ-APOE & Circ-SLC8A1.Toxicol Rep. 2025 May 29;14:102058. doi: 10.1016/j.toxrep.2025.102058. eCollection 2025 Jun. Toxicol Rep. 2025. PMID: 40520523 Free PMC article.
References
-
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. (2021) 398(10304):957–80. 10.1016/S0140-6736(21)01330-1 - DOI - PMC - PubMed
-
- Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the lancet commission on hypertension. Lancet. (2016) 388(10060):2665–712. 10.1016/S0140-6736(16)31134-5 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources